Alcon Sues Apotex To Block Generic Eye Drug

Law360, New York (November 17, 2006, 12:00 AM EST) -- Swiss company Alcon Inc. has aimed a patent infringement suit at Canadian generic drug maker Apotex Inc. over its move to sell a generic of top-selling eye allergy drug Patanol.

Alcon, the largest eye-care company in the world, and its Japanese partner Kyowa Hakko Kogyo Co. Ltd. filed the suit in the U.S. District Court for the Southern District of Indiana on Wednesday to block Apotex from making and selling the generic before Alcon’s patent expires in 2015.

Apotex notified Alcon in the beginning of October...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.